Simon N. Pimstone, CEO at Xenon Pharmaceuticals Inc. (XENE), sold 20,790 shares at $9.51 ($198K) on 2019-09-20, disclosed to the SEC on 2019-09-24.
Open-market sale of $198k XENE by CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.51 | 10,395 | $99K | 50.0% |
| 2 | $9.51 | 10,395 | $99K | 50.0% |
| Total | $9.51 avg | 20,790 | $198K | 100% |
| Filing → |
| XENE | SELL | 2022-08-16 | $10.9M | — | Filing → |
| XENE | SELL | 2022-03-08 | $2.2M | — | Filing → |
| XENE | SELL | 2022-03-08 | $77K | — | Filing → |